Waiting time and transplantation for hepatocellular cancer: A balance between tempus fugit and carpe diem
Quirino Lai, Jan Lerut, For the European Hepatocellular Cancer Liver Transplant (EurHeCaLT) Study Group – 11 September 2014
Reply
Cynthia Guy, Ayako Suzuki, Manal Abdelmalek, James Burchette, Anna Mae Diehl – 11 September 2014
Reply
Karim J. Halazun, Abbas A. Rana, Rachel E. Patzer, Benjamin Samstein, Robert S. Brown, Jean C. Emond – 11 September 2014
Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation
Natalie E. Nierenberg, Debra D. Poutsiaka, Jennifer K. Chow, Jeffrey Cooper, Lori Lyn Price, Richard B. Freeman, Richard Rohrer, David R. Snydman – 10 September 2014 – Infection after liver transplantation (LT) remains a leading cause of morbidity and mortality. The risk of infection after LT is highest in those who are most immunosuppressed, but to date, no standard blood marker of one's degree of immunosuppression or risk index has been established.
Hepatology highlights
Jean‐François Dufour – 10 September 2014
Reply
Chien‐Hsieh Chiang, Kuo‐Chin Huang – 10 September 2014
Hepatology highlights
Jean‐François Dufour – 10 September 2014
Perioperative changes in nutritional parameters and impact of graft size in patients undergoing adult living donor liver transplantation
Ahmed Hammad, Toshimi Kaido, Kohei Ogawa, Yasuhiro Fujimoto, Koji Tomiyama, Akira Mori, Tadahiro Uemura, Shinji Uemoto – 10 September 2014 – Derangements of various serum biochemical nutritional/metabolic parameters are common in patients with end‐stage liver disease who undergo liver transplantation (LT). The aim of this study was to explain the benefit of LT with respect to parameter changes and to examine the impact of the graft‐to‐recipient weight ratio (GRWR) on such changes.
A score model for the continuous grading of early allograft dysfunction severity
Eugenia Pareja, Miriam Cortes, David Hervás, José Mir, Andrés Valdivieso, José V. Castell, Agustín Lahoz – 10 September 2014 – Early allograft dysfunction (EAD) dramatically influences graft and patient outcomes. A lack of consensus on an EAD definition hinders comparisons of liver transplant outcomes and management of recipients among and within centers. We sought to develop a model for the quantitative assessment of early allograft function [Model for Early Allograft Function Scoring (MEAF)] after transplantation.
Connective tissue growth factor and integrin αvβ6: A new pair of regulators critical for ductular reaction and biliary fibrosis in mice
Liya Pi, Paulette M. Robinson, Marda Jorgensen, Seh‐Hoon Oh, Alicia R. Brown, Paul H. Weinreb, Thu Le Trinh, Protopapadakis Yianni, Chen Liu, Andrew Leask, Shelia M. Violette, Edward W. Scott, Gregory S. Schultz, Bryon E. Petersen – 9 September 2014 – Connective tissue growth factor (CTGF) is a matricellular protein that mediates cell‐matrix interaction through various subtypes of integrin receptors.